ARAMIRA
Live / Applied — Fourth extension granted (statement of use) (as of 20 Mar 2026)
What this means for you
Not registered yet, but its 16 May 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97939152
- Mark type
- Stylized text
- Filed
- 16 May 2023
- Published for opposition
- 09 Apr 2024
- Attorney of record
- Perry J. Viscounty
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical products for the treatment of cancer, pharmaceutical preparations and biological preparations for the treatment of cancer and immunological disorders; Biopharmaceuticals for the treatment of cancer, namely, antibodies, non-antibody proteins, blood and blood components, stem cells, hormones, blood factors, tumor necrosis factors; Chemical preparations for medical or pharmaceutical purposes, namely, for cancer treatment, oncology and immunotherapy for auto immune diseases; Pharmaceutical products, namely, diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing
Owner
- CG Oncology, Inc., Irvine, CA, US
- CG Oncology, Inc., Irvine, CA, US
Prosecution history
- 21 Mar 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 20 Mar 2026 — SOU EXTENSION 4 GRANTED
- 20 Mar 2026 — SOU EXTENSION 4 FILED
- 20 Mar 2026 — SOU TEAS EXTENSION RECEIVED
- 25 Oct 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 24 Oct 2025 — SOU EXTENSION 3 GRANTED
- 24 Oct 2025 — SOU EXTENSION 3 FILED
- 24 Oct 2025 — SOU TEAS EXTENSION RECEIVED
- 09 May 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 08 May 2025 — SOU EXTENSION 2 GRANTED
- 08 May 2025 — SOU EXTENSION 2 FILED
- 08 May 2025 — SOU TEAS EXTENSION RECEIVED
- 12 Jun 2024 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 12 Jun 2024 — SOU EXTENSION 1 GRANTED
- 12 Jun 2024 — SOU EXTENSION 1 FILED